Cargando…

Daratumumab: The perplexity in immunohematology with emerging horizons in myeloma therapy

CD38 is a disulfide-linked molecule present on red blood cells (RBCs) and daratumumab; an anti-CD38 monoclonal antibody is a novel agent for treating multiple myeloma patients. It also binds to the RBC along with the plasma cells in concern, creating a menace in the immunohematology workups and requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Soma, Chowdhry, Mohit, Karna, Prashant, Agrawal, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983141/
https://www.ncbi.nlm.nih.gov/pubmed/33767552
http://dx.doi.org/10.4103/ajts.AJTS_19_19